Prognosis and predictive factors in pediatric IgA nephropathy

Wenpei Liang1, Yonghua He1, Xueqing Ma1

  • 1Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Qiaokou District, Wuhan, 430030, China.

Insights

IgA nephropathy (IgAN) in children shows slow progression. While many achieve remission, recurrence is common, highlighting the need for long-term monitoring and better predictive tools for pediatric kidney disease.

Area of Science:

  • Pediatric Nephrology
  • Glomerular Diseases
  • Chronic Kidney Disease

Background:

  • IgA nephropathy (IgAN) is a primary cause of chronic kidney disease (CKD) in children.
  • Identifying prognostic markers is crucial for managing pediatric IgAN and preventing kidney failure.

Purpose of the Study:

  • Investigate predictors of poor prognosis in pediatric IgAN.
  • Analyze remission and relapse patterns and their associated factors.
  • Evaluate the impact of remission on long-term outcomes.

Main Methods:

  • Retrospective cohort study of 224 children with biopsy-proven IgAN and ≥3 years follow-up.
  • Defined poor prognosis as persistent eGFR <90 mL/min/1.73 m² for ≥3 months.
  • Utilized logistic regression, ROC analysis, and linear mixed-effects models for prediction and eGFR slope evaluation.

Main Results:

  • Independent risk factors for poor prognosis included male sex, older age, specific Oxford lesions (E1, S1), absence of gross hematuria, and lack of proteinuria remission.
  • Higher birth weight was protective; eGFR slope was influenced by age, gross hematuria, and proteinuria remission.
  • Complete kidney remission occurred in 70.98%, with a 60.38% recurrence rate. Predictors included antecedent infection and IgM deposition; risk factors included prolonged disease duration and tubular casts.

Conclusions:

  • Pediatric IgAN exhibits slow progression over 5 years with high remission rates but significant recurrence.
  • Findings underscore the necessity for extended follow-up and enhanced predictive models for pediatric IgAN management.
Abstract

Related Concept Videos

Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
791
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
254
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
331
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
549
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
484
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
552